Beijing, June 6, 2025 — ZhiFei Bio (300122), a leading Chinese biopharmaceutical firm, announced Monday that its subsidiary ZhiFei Lvzhu has received formal acceptance from China’s National Medical Products Administration (NMPA)…
© 2023 Copyright Futuresstocktrading.com – Futures Market, Investment, Trading & News